In this course you will learn the drug discovery process up to the filing of an Initial New Drug Application or IND. Each week you will learn the steps that a pharmaceutical or biotech company goes through to discover a new therapeutic drug. In this course you will be able to:
* Understand the pharmaceutical and biotechnology market a changing landscape
* Learn the major aspects of the drug discovery process, starting with target selection, to compound screening to designing lead candidates.
* Recognize current modern drug discovery based on the lock-and-key theory, which attempts to use one single compound to hit one target to combat the related disease.
* Increase understanding of the various drug discovery tools and methods that are used for finding, identifying and designing a new drug.
* Define and understand the regulatory responsibilities for drug discovery to file an Investigational New Drug Application (IND).
This course is intended as part 1 of a series: Drug Discovery, Drug Development and Drug Commercialization. We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place.
Who is this class for: This class is for professionals and students interested in better understanding the process of drug discovery in the pharmaceutical and biotech industry as well as anyone who wants to learn how new drugs are discovered.
Pharmaceutical & Biotechnology Industry Landscape
In this module course lead Dr. Williams Ettouati begins by giving a landscape overview of the Pharma and Biotechnology landscape.
Graded: Pharma and Biotech
Drug Discovery: Proteomics, Genomics
This week we will be hearing from Phillip Bourne, PhD. Dr. Bourne was, at the time of this recording, the Associate Vice Chancellor for Innovation and Industrial Alliances in the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences. Since that time, he has been named the first Associate Director for Data Science at the United States National Institutes of Health.
Graded: Drug Discovery: Proteomics, Genomics
Compound Selection & Preclinical Studies
This week we will hear from Ronald Christopher, Ph.D. Dr. Ronald Christopher, Vice President of Preclinical Trials at Arena Pharmaceuticals.
Graded: Compound Selection and Pre-clinical Studies
Challenges in Fragment Based Drug Discovery for Protein Kinases
In this module we will hear from Stephen Burley, M.D., Ph.D. At the time of this recording, Director of the Center for Integrative Proteomics at Rutgers University. He is now the Director of the Protein Data Bank and remains an Adjunct Professor at the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences.
Graded: Challenges in Fragment Based Drug Discovery for Protein Kinases
Key Concepts in Drug Delivery
This module we hear from Professor of Clinical Pharmacy and Pediatrics, Brookie Best, Pharm. D., of UCSD's Skaggs School of Pharmacy and Pharmaceutical Sciences.
Graded: Concepts in Drug Delivery Quiz